Today's Daily Dose brings you news about the IPO of a cannabis firm; stock offerings of Evolus and Cara, upcoming regulatory catalyst of Immunomedics and an update on CTI Biopharma's Type B meeting with the FDA for its lead product candidate Pacritinib.
from RTT - Biotech https://ift.tt/2zSphaz
via IFTTT
No comments:
Post a Comment